Association Between Buprenorphine Treatment Gaps, Opioid Overdose, and Health Care Spending in US Medicare Beneficiaries With Opioid Use Disorder.

ABSTRACT:

Importance

Nonadherence to buprenorphine may increase patient risk of opioid overdose and increase health care spending. Quantifying the impacts of nonadherence can help inform clinician practice and policy.

Objective

To estimate the association between buprenorphine treatment gaps, opioid overdose, and health care spending.

Design, setting, and participants

This longitudinal case-control study compared patient opioid overdose and health care spending in buprenorphine-treated months with treatment gap months. Individuals who were US Medicare fee-for-service beneficiaries diagnosed with opioid use disorder who received at least 1 two-week period of continuous buprenorphine treatment between 2010 and 2017 were included. Analysis took place between January 2010 and Decem

SUBMITTER: Gibbons JB 

PROVIDER: S-EPMC9535497 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature